199 related articles for article (PubMed ID: 8509254)
1. [Anti-arrhythmic therapy of ventricular arrhythmias. Assessing benefit and risk].
Haberl R; Steinbeck G
Internist (Berl); 1993 May; 34(5):436-43. PubMed ID: 8509254
[No Abstract] [Full Text] [Related]
2. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
3. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
[No Abstract] [Full Text] [Related]
4. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
Doherty JU; Fuchs S; Tecce MA
Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
[TBL] [Abstract][Full Text] [Related]
5. [Antiarrhythmia agents in heart failure].
Duc P
Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic therapy for the prevention of sudden cardiac death.
Cairns J; Kerr C; Teo K
Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
[No Abstract] [Full Text] [Related]
7. [Prevention of sudden (rhythm-induced) cardiac death].
Andresen D; Behrens S; Arntz R; Brüggemann T
Internist (Berl); 1993 May; 34(5):423-35. PubMed ID: 8509253
[No Abstract] [Full Text] [Related]
8. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
[TBL] [Abstract][Full Text] [Related]
9. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
Alboni P
Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
[TBL] [Abstract][Full Text] [Related]
10. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
11. Overview of trends in the control of cardiac arrhythmia: past and future.
Singh BN
Am J Cardiol; 1999 Nov; 84(9A):3R-10R. PubMed ID: 10568654
[No Abstract] [Full Text] [Related]
12. [Heart failure and treatment of ventricular arrhythmias].
Junga G; Duru F; Candinas R
Praxis (Bern 1994); 1999 Feb; 88(6):215-22. PubMed ID: 10081339
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility and adverse effects of amiodarone therapy.
Roberts M
AACN Adv Crit Care; 2010; 21(4):333-8; quiz 339-40. PubMed ID: 21045568
[No Abstract] [Full Text] [Related]
14. Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
Auer J; Lamm G
Crit Care Med; 2011 Jan; 39(1):204-5. PubMed ID: 21178539
[No Abstract] [Full Text] [Related]
15. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey JY; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann S; ; ; ;
Eur Heart J; 2006 Aug; 27(16):1979-2030. PubMed ID: 16885201
[No Abstract] [Full Text] [Related]
16. Sotalol for cardiac arrhythmias.
Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
[No Abstract] [Full Text] [Related]
17. Meta-analysis of antiarrhythmic drug trials.
Connolly SJ
Am J Cardiol; 1999 Nov; 84(9A):90R-93R. PubMed ID: 10568666
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of cardiac arrhythmias in the aged].
Ziegelmeyer W
Wien Med Wochenschr; 1993; 143(3-4):72-5, 78-9. PubMed ID: 8506690
[TBL] [Abstract][Full Text] [Related]
19. Early postmyocardial infarction ventricular arrhythmias.
Brugada P; Andries EW
Cardiovasc Clin; 1992; 22(1):165-80. PubMed ID: 1728424
[No Abstract] [Full Text] [Related]
20. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
Konecná P; Dvorák R; Semrád B
Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
